Evidence map›Paper›PMID 35209205›Full record

ArticleMolecules (Basel, Switzerland)2022

PLLA Coating of Active Implants for Dual Drug Release.

Katharina Wulf, Madeleine Goblet, Stefan Raggl, Michael Teske, Thomas Eickner, Thomas Lenarz, Niels Grabow, Gerrit Paasche

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Frontiers in bioengineering and biotechnology · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Katharina WulfInstitute for Biomedical Engineering, University Medical Center Rostock, 18119 Rostock, Germany.ORCID 0000-0002-9891-5174
Madeleine GobletDepartment of Otorhinolaryngology, Head and Neck Surgery and Hearing4all Cluster of Excellence, Hannover Medical School, 30625 Hannover, Germany.
Stefan RagglMED-EL Medical Electronics, Fuerstenweg 77a, 6020 Innsbruck, Austria.
Michael TeskeInstitute for Biomedical Engineering, University Medical Center Rostock, 18119 Rostock, Germany.
Thomas EicknerInstitute for Biomedical Engineering, University Medical Center Rostock, 18119 Rostock, Germany.
Thomas LenarzDepartment of Otorhinolaryngology, Head and Neck Surgery and Hearing4all Cluster of Excellence, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-9307-5989
Niels GrabowInstitute for Biomedical Engineering, University Medical Center Rostock, 18119 Rostock, Germany.
Gerrit PaascheDepartment of Otorhinolaryngology, Head and Neck Surgery and Hearing4all Cluster of Excellence, Hannover Medical School, 30625 Hannover, Germany.
University of Rostock · DEMedizinische Hochschule Hannover · DEMED-EL (Austria) · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cochlear implants, like other active implants, rely on precise and effective electrical stimulation of the target tissue but become encapsulated by different amounts of fibrous tissue. The current study aimed at the development of a dual drug release from a PLLA coating and from the bulk material to address short-term and long-lasting release of anti-inflammatory drugs. Inner-ear cytocompatibility of drugs was studied in vitro. A PLLA coating (containing diclofenac) of medical-grade silicone (containing 5% dexamethasone) was developed and release profiles were determined. The influence of different coating thicknesses (2.5, 5 and 10 µm) and loadings (10% and 20% diclofenac) on impedances of electrical contacts were measured with and without pulsatile electrical stimulation. Diclofenac can be applied to the inner ear at concentrations of or below 4 × 10

Indexed as

Anti-Inflammatory AgentsCochlear ImplantsDexamethasoneDiclofenacDrug Delivery SystemsAnimalsCoated Materials, BiocompatibleDrug LiberationRatsRats, Sprague-DawleyAnti-Inflammatory AgentsCoated Materials, BiocompatibleDexamethasoneDiclofenaccochlear implantdiclofenacdual drug deliveryimpedance measurementsPLLA coatingspiral ganglion neuron

Identifiers

PMID35209205
PMCPMC8875406
OpenAlexW4214735957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.